Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Inflammatory Myofibroblastic Tumor — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Mesenchymal Cell Neoplasm
Fibroblastic Neoplasm
Intermediate Fibroblastic Neoplasm
Inflammatory Myofibroblastic Tumor

Subtype

Inflammatory Myofibroblastic Tumor

CI-CAN-00002917IMTExplore in graph →

Non-malignant2 active trials10 evidence items

NCIt: C6481
OncoTree: IMT
DOID: 0050905
UMLS CUI: C0334121

Overview
Statistics
Survival
Genomics
Variants & evidence10
Drugs2
Trials7
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (8)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–8 of 8 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.
· J Clin Oncol · 2017 · PMID 28787259 · validated civic_curation pubmed
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.
· Am J Hematol · 2018 · PMID 29352732 · validated civic_curation pubmed
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
· Lancet Oncol · 2013 · PMID 23598171 · validated civic_curation pubmed
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
· Neuro Oncol · 2022 · PMID 35395680 · validated civic_curation pubmed
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
· N Engl J Med · 2010 · PMID 20979472 · validated civic_curation pubmed
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
· Cancer Res · 1999 · PMID 10383129 · validated civic_curation pubmed
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.
· Cancer Res · 2010 · PMID 21030459 · validated civic_curation

Showing 1–8 of 8 publications

Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.

· Cancer Discov · 2014 · PMID 24875859 · validated civic_curation pubmed